Related Experiment Video
Updated: Jul 4, 2026
09:34
Uptake of New Lipid-coated Nanoparticles Containing Falcarindiol by Human Mesenchymal Stem Cells
Published on: February 9, 2019
Lantadenes and their esters as potential antitumor agents
M Sharma1, P D Sharma, M P Bansal
1University Institute of Pharmaceutical Sciences, Panjab University, Chandigarh-160014, India.
Journal of Natural Products
|June 17, 2008
Summary
New lantadenes from Lantana camara show promising antitumor activity. The study synthesized novel compounds and evaluated their potential to inhibit squamous cell carcinogenesis, highlighting structure-activity relationships for future drug development.
Area of Science:
- Natural Products Chemistry
- Pharmacology
- Cancer Research
Background:
- Lantadenes are pentacyclic triterpenoids derived from Lantana camara.
- These compounds have shown potential biological activities, warranting further investigation.
Purpose of the Study:
- To synthesize and characterize new lantadene derivatives and their methyl esters.
- To evaluate the cytotoxicity of these compounds against human cancer cell lines.
- To assess the in vivo tumor inhibitory potential of the most active compounds.
Main Methods:
- Chemical synthesis of five new lantadenes and their methyl esters.
- Cytotoxicity screening against four human cancer cell lines.
- In vivo studies using a mouse model of squamous cell carcinogenesis induced by DMBA and promoted by TPA.
- Histopathological analysis and structure-activity relationship (SAR) evaluation.
Main Results:
- Five new lantadenes (14-18) and their methyl esters (20-24) were successfully synthesized and characterized.
- Compounds 15, 16, 21, and 22 exhibited significant cytotoxicity and in vivo tumor inhibitory effects.
- Histopathological studies supported the observed antitumor activity.
- Structure-activity relationship analysis indicated the importance of substituents at C-22 and C-17.
Conclusions:
- Novel lantadene derivatives possess significant antitumor properties.
- The substitution pattern at specific positions (C-22 and C-17) is crucial for enhancing antitumor activity.
- These findings suggest potential for developing lantadenes as anticancer agents.
Related Concept Videos
01:18Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists
Endothelins (ETs) are potent vasoactive peptides critical in the human body's various physiological and pathological processes. One of the most promising therapeutic strategies for treating pulmonary arterial hypertension (PAH) involves counteracting the effects of these endothelins using a class of drugs known as endothelin receptor antagonists.
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme (ECE). Of...
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme (ECE). Of...
01:10Drugs that Destabilize Microtubules
Microtubules are dynamic structures and can be regulated by microtubule targeting agents (MTAs). Microtubule destabilizing drugs are a class of MTAs that destabilize and prevent microtubules' polymerization. Both natural and synthetic chemicals can be found under this class of drugs. Vincristine and vinblastine, two vinca alkaloids, and colchicine were among the first to be discovered. These drugs can affect cells in various ways, either by inducing a change in cell morphology, preventing...
01:19Antiasthma Drugs: Leukotriene Modifiers
Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
Leukotriene modifiers work through two distinct mechanisms:
Leukotriene modifiers work through two distinct mechanisms:
01:21Antiprotozoal Agents
Leishmaniasis is a widespread parasitic disease caused by several Leishmania species. It affects millions of people each year and remains a major public health problem in endemic regions. First-line treatment relies on pentavalent antimonials, including meglumine antimoniate and sodium stibogluconate. Even so, how these drugs work has not been fully clear, especially their interaction with parasite-specific biochemical pathways. One key target is trypanothione reductase (TR), an enzyme that...
01:15Drugs that Stabilize Microtubules
Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
01:27Chemotherapy-Induced Nausea and Vomiting: 5-HT3 Receptor Antagonists
5-HT3 receptor antagonists, such as dolasetron, granisetron (Kytril), ondansetron (Zofran), and palonosetron (Axoli), are crucial in managing chemotherapy-induced nausea and vomiting (CINV) and postoperative nausea. These drugs selectively block 5-HT3 receptors in the visceral vagal and spinal afferent nerves, chemoreceptor trigger zone, and the vomiting center. They have a rapid onset of action and can be given as a single dose before chemotherapy. Ondansetron and granisetron, in particular,...